or Try an Advanced Search...

    Technical Analysis for SAVA - Cassava Sciences, Inc.

    Grade Last Price % Change Price Change
    D 25.96 3.10% 0.78
    SAVA closed down 4.55 percent on Wednesday, November 13, 2024, on 67 percent of normal volume.
    6 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Flat
    Historical SAVA trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 3.10%
    MACD Bearish Signal Line Cross Bearish 3.10%
    20 DMA Resistance Bearish -1.59%
    20 DMA Resistance Bearish -4.06%
    50 DMA Resistance Bearish -4.06%
    MACD Bullish Signal Line Cross Bullish -4.06%
    Gapped Up Strength -4.06%
    20 DMA Resistance Bearish -3.67%
    50 DMA Resistance Bearish -3.67%
    Pocket Pivot Bullish Swing Setup -3.67%
    Older End-of-Day Signals for SAVA ...

       Recent Intraday Alerts

    Alert Time
    Up 5% 8 minutes ago
    Up 3% 36 minutes ago
    Rose Above 10 DMA 44 minutes ago
    Up 2% about 1 hour ago
    Up 1% about 1 hour ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    SAVA Chart by TradingView
    Basic chart:

    Profile

    Cassava Sciences, Inc. develops drugs for nervous system disorders in the United States. It engages in developing FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; PTI-125, a small molecule drug candidate to treat Alzheimer's disease; and PTI-125DX, a blood-based diagnostic/biomarker to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biology Pain Neuroscience Alzheimer's Disease Mental Health Biomarkers Psychiatric Diagnosis Psychiatry Nervous System Disorders Transdermal Abnormal Psychology

    Is SAVA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 12 What Makes Cassava Sciences (SAVA) a New Buy Stock
    Nov 11 Anavex, Cassava Sciences, Panax Ginseng, And The Long-Term Treatment Of Alzheimer's Disease
    Nov 8 Friday's Top 5 Trending Stocks: What's The Scoop On GameStop, SoFi, Tesla?
    Nov 8 Cassava Sciences: With Almost Half The Float Shorted, Results Could Be Interesting
    Nov 7 Cassava Sciences: Pivotal Alzheimer's Data May Push Stock Toward Book Value
    Nov 7 Cassava Q3 Earnings Review: It Feels Like The End May Be Nigh
    Nov 7 Cassava Sciences, Inc. (SAVA) Q3 2024 Earnings Call Transcript
    Nov 7 Cassava Sciences beats in Q3 ahead of key Alzheimer’s readout
    Nov 7 Cassava Sciences GAAP EPS of -$0.58 beats by $0.30
    Nov 7 Cassava Sciences Reports Q3 2024 Financial and Operating Results
    See more SAVA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 42.2
    52 Week Low 8.79
    Average Volume 1,692,397
    200-Day Moving Average 22.84
    50-Day Moving Average 27.56
    20-Day Moving Average 26.81
    10-Day Moving Average 25.93
    Average True Range 1.87
    RSI (14) 43.50
    ADX 11.61
    +DI 17.99
    -DI 23.04
    Chandelier Exit (Long, 3 ATRs) 24.79
    Chandelier Exit (Short, 3 ATRs) 29.06
    Upper Bollinger Bands 29.55
    Lower Bollinger Band 24.07
    Percent B (%b) 0.2
    BandWidth 20.44
    MACD Line -0.44
    MACD Signal Line -0.42
    MACD Histogram -0.0262
    Fundamentals Value
    Market Cap 1.06 Billion
    Num Shares 42.2 Million
    EPS -2.29
    Price-to-Earnings (P/E) Ratio -11.00
    Price-to-Sales 0.00
    Price-to-Book 6.82
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 28.18
    Resistance 3 (R3) 28.45 27.73 27.68
    Resistance 2 (R2) 27.73 26.96 27.59 27.51
    Resistance 1 (R1) 26.45 26.49 26.09 26.18 27.35
    Pivot Point 25.73 25.73 25.55 25.59 25.73
    Support 1 (S1) 24.45 24.96 24.09 24.18 23.01
    Support 2 (S2) 23.73 24.49 23.59 22.85
    Support 3 (S3) 22.45 23.73 22.68
    Support 4 (S4) 22.18